IL17A and infection: Erika et al. demonstrated that the mean concentration of IL-17A levels was 37.28 pg/ml, peaking during late gestation, and that this peak coincides with a critical developmental window where the fetus (and later the neonate) exhibit immature neuroimmune systems that are both qualitatively and quantitatively distinct from those of adults, resulting in heightened susceptibility to infection.